FindTrial
Sign In

The application of deep muscle relaxation and low pneumoperitoneum pressure combined with sugammadex to antagonize residual muscle relaxation in pediatric laparoscopic daytime surgery to promote the realization of ERAS

The application of deep muscle relaxation and low pneumoperitoneum pressure combined with sugammadex to antagonize residual muscle relaxation in pediatric laparoscopic daytime surgery to promote the realization of ERAS

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023715
Enrollment
Unknown
Registered
2019-06-08
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inguinal hernia

Interventions

Experimental groups:sugammadex to antagonize residual muscle relaxation
Control group:Neostigmine

Sponsors

Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 2-12 years; 2. ASA I or II; 3. Laparoscopic hernia repair under general anesthesia; 4. Signing informed consent.

Exclusion criteria

Exclusion criteria: 1. Previously allergic to inhaled anesthetics or propofol; 2. History of congenital heart disease; 3. Recent history of upper respiratory infections; 4. Participate in other clinical trials.

Design outcomes

Primary

MeasureTime frame
TOF ratio;Heart rate;Systolic blood pressure;Diastolic blood pressure;time for extubation;—

Countries

China

Contacts

Public ContactZhang Ruidong

Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine

doctorruidong@163.com+86 18221150942

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026